StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.00 (-2.01%)

Close on Nov 17, 2026Market cap $457.03KP/E –Yield –

Arcadia Biosciences cash

Cash and short-term investments held at the end of each period.

Arcadia Biosciences's cash was $4.18M at Jun 30, 2026. For fiscal 2025 it was $4.56M, up 7.6% from the year before. Over ten years it grew -21.3% a year on average. The highest annual figure on record is $50.56M in fiscal 2016.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.56M+7.6%
FY2024Dec 31, 2024$4.24M-63.6%
FY2023Dec 31, 2023$11.64M-43.6%
FY2022Dec 31, 2022$20.64M-28.0%
FY2021Dec 31, 2021$28.69M+11.8%
FY2020Dec 31, 2020$25.67M+1.3%
FY2019Dec 31, 2019$25.33M+16.1%
FY2018Dec 31, 2018$21.82M+67.6%
FY2017Dec 31, 2017$13.02M-74.2%
FY2016Dec 31, 2016$50.56M+0.6%
FY2015Dec 31, 2015$50.24M+203.2%
FY2014Dec 31, 2014$16.57M+484.5%
FY2013Dec 31, 2013$2.84M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.18M-6.0%
Q1 FY2026Mar 31, 2026$3.72M+17.8%
Q4 FY2025Dec 31, 2025$4.56M+7.6%
Q3 FY2025Sep 30, 2025$5.89M-10.5%
Q2 FY2025Jun 30, 2025$4.44M-45.2%
Q1 FY2025Mar 31, 2025$3.16M-62.8%
Q4 FY2024Dec 31, 2024$4.24M-63.6%
Q3 FY2024Sep 30, 2024$6.58M-58.1%
Q2 FY2024Jun 30, 2024$8.11M-56.2%
Q1 FY2024Mar 31, 2024$8.50M-63.0%
Q4 FY2023Dec 31, 2023$11.64M-43.6%
Q3 FY2023Sep 30, 2023$15.70M-30.9%
Q2 FY2023Jun 30, 2023$18.51M-12.8%
Q1 FY2023Mar 31, 2023$23.00M-6.3%
Q4 FY2022Dec 31, 2022$20.64M-28.0%
Q3 FY2022Sep 30, 2022$22.72M-36.0%
Q2 FY2022Jun 30, 2022$21.23M-51.7%
Q1 FY2022Mar 31, 2022$24.55M-52.7%
Q4 FY2021Dec 31, 2021$28.69M+11.8%
Q3 FY2021Sep 30, 2021$35.53M+248.3%
Q2 FY2021Jun 30, 2021$43.98M+182.0%
Q1 FY2021Mar 31, 2021$51.94M+224.2%
Q4 FY2020Dec 31, 2020$25.67M+1.3%
Q3 FY2020Sep 30, 2020$10.20M-67.0%
Q2 FY2020Jun 30, 2020$15.60M-22.1%
Q1 FY2020Mar 31, 2020$16.02M-10.0%
Q4 FY2019Dec 31, 2019$25.33M+16.1%
Q3 FY2019Sep 30, 2019$30.90M+25.6%
Q2 FY2019Jun 30, 2019$20.03M-30.0%
Q1 FY2019Mar 31, 2019$17.79M-12.9%
Q4 FY2018Dec 31, 2018$21.82M+67.6%
Q3 FY2018Sep 30, 2018$24.60M+56.7%
Q2 FY2018Jun 30, 2018$28.60M-35.3%
Q1 FY2018Mar 31, 2018$20.42M-57.9%
Q4 FY2017Dec 31, 2017$13.02M-74.2%
Q3 FY2017Sep 30, 2017$15.70M-70.9%
Q2 FY2017Jun 30, 2017$44.18M–
Q1 FY2017Mar 31, 2017$48.53M–
Q4 FY2016Dec 31, 2016$50.56M–
Q3 FY2016Sep 30, 2016$53.89M–

More Arcadia Biosciences figures

See a number that looks wrong?